glp-1 studies Receptor Agonists as Treatments for Type 2 Diabetes GLP-1R Agonists for Weight Loss

While this research is promising, the benefits extend far beyond those with neurological conditions

Insulin-sensitizing drugs are the second-line treatment, with metformin being the most recommended therapeutic option, to improve peripheral insulin sensitivity in order to decrease insulin levels and, consequently, insulin-mediated stimulation of ovarian androgen secretion 17

K., Louhivuori, L

& Mikut, R

Kaehler KC, Russo PAJ, Katenkamp D, Kreusch T, Neuber K, Schwarz T, et al

Liraglutide and Semaglutide are both GLP-1 receptor agonists used in the treatment of type 2 diabetes as well as weight loss in non-diabetic individuals